Neutrophil-lymphocyte ratio in the immune checkpoint inhibitors-related atherosclerosis

Eur Heart J. 2021 Jun 7;42(22):2215. doi: 10.1093/eurheartj/ehab158.

Authors

Nan Zhang¹, Gary Tse¹, Tong Liu¹

Affiliation

¹ Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.

PMID: 33748846
DOI: 10.1093/eurheartj/ehab158

No abstract available

Publication types

Editorial
Comment

MeSH terms

Atherosclerosis* / chemically induced
Humans
Immune Checkpoint Inhibitors*
Lymphocyte Count
Lymphocytes
Neutrophils

Substances

Immune Checkpoint Inhibitors